Arthur Aung, Hematology Oncology Fellow at Northwell Health Northshore, shared a post on X:
“Amazing panel discussion on long-term immunotherapy outcomes in NSCLC, dual checkpoint blockade, and how we still need to refine patient selection. Grateful to learn from this group.”
